Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusion-Reference-Cited by-同舟云学术

Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusion

Published:2011-10 Issue:2 Volume:231 Page:261-271
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Ziegler Robin J.,Salegio Ernesto A.,Dodge James C.,Bringas John,Treleaven Christopher M.,Bercury Scott D.,Tamsett Thomas J.,Shihabuddin Lamya,Hadaczek Piotr,Fiandaca Massimo,Bankiewicz Krystof,Scheule Ronald K.

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference41 articles.

1. AAV8-mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of a mouse model of Niemann–Pick disease;Barbon;Mol. Ther.,2005

2. Determination of cerebrospinal fluid production rate using a push-pull perfusion procedure in the conscious rat;Baudrie;Fundamental and Clinical Pharmacology,1990

3. Intracerebroventricular delivery of glucocerebrosidase reduces substrates and increases lifespan in a mouse model of neuronopathic Gaucher disease;Cabrera-Salazar;Exp. Neurol.,2010

4. Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis;Chang;Mol. Ther.,2008

5. Fabry disease: clinical spectrum and evidence-based enzyme replacement therapy;Desnick;Nephrol. Ther.,2006

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier;Molecular Therapy;2023-03

2. Blood-brain barrier delivery for lysosomal storage disorders with IgG-lysosomal enzyme fusion proteins;Advanced Drug Delivery Reviews;2022-05

3. Addressing neurodegeneration in lysosomal storage disorders: Advances in Niemann Pick diseases;Neuropharmacology;2020-07

4. Advancing gene therapies, methods, and technologies for Parkinson’s Disease and other neurological disorders;Neurologia i Neurochirurgia Polska;2020-06-30

5. Bi-functional IgG-lysosomal enzyme fusion proteins for brain drug delivery;Scientific Reports;2019-12